Lymphocyte Antigen 9 (CD229) (Middle Region) Peptid
CD229
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle LY9 (CD229) Produkte
- LY9 (CD229) (Lymphocyte Antigen 9 (CD229))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- ITLMCSVKGA EKSVLYSWTP REPHASESNG GSILTVSRTP CDPDLPYICT
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- LY9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LY9 (CD229) (Lymphocyte Antigen 9 (CD229))
- Synonyme
- LY9 Peptide, CD229 Peptide, SLAMF3 Peptide, hly9 Peptide, mLY9 Peptide, AI893573 Peptide, Lgp100 Peptide, Ly-9 Peptide, T100 Peptide, lymphocyte antigen 9 Peptide, LY9 Peptide, Ly9 Peptide
- Hintergrund
-
LY9 belongs to the SLAM family of immunomodulatory receptors and interacts with the adaptor molecule SAP.
Alias Symbols: hly9, mLY9, CD229, SLAMF3
Protein Size: 405 - Gen-ID
- 4063
- NCBI Accession
- NM_001033667, NP_001028839
- UniProt
- Q05CA2
-
Sie sind hier:
